Baohua Li, Xiaoyun Wan, Yun Liang, Bingjian Lu, Weiguo Lu
{"title":"Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.","authors":"Baohua Li, Xiaoyun Wan, Yun Liang, Bingjian Lu, Weiguo Lu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the clinical characteristics and outcomes of patients with re-recurrent gestational trophoblastic neoplasia (GTN).</p><p><strong>Study design: </strong>A total of 547 patients with typical GTN at our institution from 2000-2012 were enrolled in this retrospective study. Of 547 cases, 29 relapsed after initial remission, and 7 of 29 patients with recurrent GTN had repeat relapses. The detailed clinical charac- teristics of patients with re-recurrent GTN were eval- uated.</p><p><strong>Results: </strong>The recurrence and re-recurrence rates in 547 patients with GTN were 5.3% and 24%, respective- ly. In 7 patients with re-recurrent GTN the mean age was 43 years. The mean level of serum [-hCG before each treatment was 11,405 IU/L. The mean time interval from last treatment to recurrence was 38 months. All 7 patients received first- and second-line chemotherapy, and 4 of them required salvage chemotherapy. The total number of chemotherapy courses administered was 137 (mean= 6). In conjunction with chemotherapy, surgery was performed in all 7 patients. After final treatment 7 patients had a median follow-up of 20 months. Although 1 died secondary to disease progression, the remaining 6 achieved serologic complete remission.</p><p><strong>Conclusion: </strong>Our anal- ysis suggests that surgical intervention and intensive chemotherapy could be equally important for the treatment of . the patients with re-recurrent GTN. Be- cause the patients have a favorable prognosis, the principles of treatment for re-recurrent GTN should strive to cure.disease rather than simply relieve the symptoms of disease or delay the time of relapse.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"61 9-10","pages":"494-502"},"PeriodicalIF":0.2000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"生殖医学杂志","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To analyze the clinical characteristics and outcomes of patients with re-recurrent gestational trophoblastic neoplasia (GTN).
Study design: A total of 547 patients with typical GTN at our institution from 2000-2012 were enrolled in this retrospective study. Of 547 cases, 29 relapsed after initial remission, and 7 of 29 patients with recurrent GTN had repeat relapses. The detailed clinical charac- teristics of patients with re-recurrent GTN were eval- uated.
Results: The recurrence and re-recurrence rates in 547 patients with GTN were 5.3% and 24%, respective- ly. In 7 patients with re-recurrent GTN the mean age was 43 years. The mean level of serum [-hCG before each treatment was 11,405 IU/L. The mean time interval from last treatment to recurrence was 38 months. All 7 patients received first- and second-line chemotherapy, and 4 of them required salvage chemotherapy. The total number of chemotherapy courses administered was 137 (mean= 6). In conjunction with chemotherapy, surgery was performed in all 7 patients. After final treatment 7 patients had a median follow-up of 20 months. Although 1 died secondary to disease progression, the remaining 6 achieved serologic complete remission.
Conclusion: Our anal- ysis suggests that surgical intervention and intensive chemotherapy could be equally important for the treatment of . the patients with re-recurrent GTN. Be- cause the patients have a favorable prognosis, the principles of treatment for re-recurrent GTN should strive to cure.disease rather than simply relieve the symptoms of disease or delay the time of relapse.
期刊介绍:
The Journal of Reproductive Medicine® has been the essential tool of Obstetricians and Gynecologists since 1968. As a highly regarded professional journal and the official periodical of six medical associations, JRM® brings timely and relevant information on the latest procedures and advances in the field of reproductive medicine. Published bimonthly, JRM® contains peer-reviewed articles and case reports submitted by top specialists. Common topics include research, clinical practice, and case reports related to general obstetrics and gynecology, infertility, female cancers, gynecologic surgery, contraception, and medical education.